Global DNA Vaccine Market to Grow at a CAGR of 55% by 2023: Surging Investments in the Development of Third Generation Vaccination Technology

News provided by

Research and Markets

28 Jul, 2017, 14:00 BST

DUBLIN, July 28, 2017 /PRNewswire/ --

The "Global DNA Vaccine Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering.

The global DNA vaccine market is anticipated to rise with a CAGR of about 55% during the forecast years 2016-2023.

Increasing adoption of DNA vaccines for animal healthcare is driving the global DNA vaccines market. Some other factors that includes rising prevalence of chronic and infectious diseases, surging investments in the development of third generation vaccination technology and low cost of DNA vaccines as compared to other gene therapy technologies also helps to drive the market growth.

The global DNA vaccine market is segmented on the basis of geography into North America, Europe, Asia Pacific and rest of the world. Asia pacific market is estimated to grow at a fast pace as compared to other regions due to rising awareness among consumers regarding the advantages of immunization in case of H1N1 influenza and Hepatitis B. For instance, State food and drug administration in China has designated 11 biotech companies for the development of H1N1 influenza vaccine. North America region dominates the majority of market revenue among other regions. Increasing prevalence of infectious and chronic diseases in countries such as US and Canada is driving the demand of effective vaccination technology. Mortality rate due to chronic and infectious disease has increased in the United States to about 360,000 every year.

Companies Mentioned

  • Novartis Animal Health
  • Inovio Biomedical Corp
  • Merck & Co.
  • Dendreon Corporation
  • Astellas Pharma
  • Vical
  • Sanofi
  • Tekmira Pharmaceuticals
  • Glaxosmithkline Inc.
  • Pfizer Pharmaceuticals
  • Advance Bioscience Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Xenetic Biosciences Inc.
  • Qed Biosciences Inc.
  • Tolerion Inc.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Global Dna Vaccines Market By Region

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/cw4gfw/global_dna

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets